{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-258519","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.684186+00:00","generated_at":"2026-05-17T01:32:52.464206+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ResMed Q1 FY2026 revenue +9% to $1.34B; non-GAAP EPS $2.55 (+16%); dividend $0.60","bullets":["Revenue $1,335.6M (+9% YoY, +8% constant currency); diluted EPS $2.37, non-GAAP EPS $2.55 (+16%).","Gross margin up 290 bps to 61.5%; non-GAAP gross margin 62.0% (up 280 bps).","Operating cash flow $457M; income from operations +15% (+19% non-GAAP).","Board declared quarterly dividend of $0.60 per share, payable Dec 18 to holders of record Nov 13."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-258519","json":"https://secwatch.observer/filing/0001193125-25-258519.json","markdown":"https://secwatch.observer/filing/0001193125-25-258519.md","text":"https://secwatch.observer/filing/0001193125-25-258519.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312525258519/0001193125-25-258519-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312525258519/d92301d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:32:52.464206+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}